Diabetic Ketoacidosis and hyperosmolar hyperglucemic state in COVID-19. Case report

Authors

  • Goethe Salomón Sacoto Flores Médico. Especialista en Medicina Interna. Hospital Homero Castanier Crespo. Clínica. Hospitalización COVID-19. Cuenca-Azuay-Ecuador. https://orcid.org/0000-0002-8114-0114
  • Galo Dario Sánchez Coraizaca Médico. Hospital Homero Castanier Crespo. Clínica. UCI COVID-19. Azogues-Cañar-Ecuador. https://orcid.org/0000-0003-4695-3096
  • Luis Andrés Cajilema Acero Médico. Hospital Homero Castanier Crespo. Clínica. Hospitalización COVID-19. El Tambo - Cañar - Ecuador.
  • María Ximena Sanango Jara Médica. Hospital Homero Castanier Crespo. Clínica. Hospitalización COVID-19. Azogues-Cañar-Ecuador. https://orcid.org/0000-0003-2207-3131

DOI:

https://doi.org/10.18537/RFCM.39.01.05

Keywords:

COVID-19, Diabetes Mellitus, diabetic ketoacidosis

Abstract

Introduction: Introduction: Diabetes Mellitus (DM) is an independent risk factor to predict severity in COVID-19 infection.

Clinical cases: we present four cases of hyperglycemic seizures type hyperosmolar nonketotic state (EHNC) and diabetic ketoacidosis (DKA) associated with COVID-19, three with a history of DM and one with a new diagnosis of DM. The outcome was fatal for the CAD cases and the EHNC case was discharged in stable condition.

Conclusion: it is essential to understand the presentation characteristics of acute complications of diabetes in patients with COVID-19 and to suspect this type of metabolic alterations in SARS-CoV-2 infection, important aspects for a timely diagnosis and treatment, greatly improving the prognosis of patients.

Downloads

Download data is not yet available.

Published

2021-09-16